Enterome
Enterome is a pharmaceutical company founded in 2012 by Pierre Belichard.
14
Funding Rounds
$332.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| St******* Du*** EH***** |
|
- | - |
| Pi**** Be******* |
|
- |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pi**** Be******* |
|
- | |
| La** Gr****** | - | - | - |
| Ha********** Wo**** | - | - | |
| Ro*** Ga***** | - | - | |
| Pi**** Ca******* | - | - | |
| Ge***** Ge***** | - | - | - |
| Ma** Th***** | - | - | |
| Is****** de Cr***** | - | - | - |
| Lu** Ma**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Enterome has raised a total of $276.22m in funding over 14 rounds.
Key Insights:
- Enterome October 2023 Series F Funding Round: $3.2m
- Enterome July 2022 Series F Funding Round: $43m
- Enterome , June 2020: $51.9m
- Enterome June 2020 Series E Funding Round: $52m
- Enterome Series D round, January 2017: $38.5m
- Enterome January 2017 Series D Funding Round: $35m
- Enterome April 2016 Series C Funding Round: $16m
- Enterome May 2014 Series B Funding Round: $12m
- Enterome March 2012 Series A Funding Round: $8.2m
- Enterome Series A round: $6.62m
- Enterome March 2012 Series A Funding Round: $8.2m
- Enterome January 2011 Seed Funding Round: $1.6m
- Enterome Series E round June 2020: $46.3m
- Enterome Series B round May 2014: $10m
Enterome October 2023 Series F Funding Round
$3.2m
Enterome July 2022 Series F Funding Round
$43m
Enterome , June 2020
$51.9m
Enterome June 2020 Series E Funding Round
$52m
Enterome Series D round, January 2017
$38.5m
Enterome January 2017 Series D Funding Round
$35m
Enterome April 2016 Series C Funding Round
$16m
Enterome May 2014 Series B Funding Round
$12m
Enterome March 2012 Series A Funding Round
$8.2m
Enterome Series A round
$6.62m
Enterome March 2012 Series A Funding Round
$8.2m
Enterome January 2011 Seed Funding Round
$1.6m
Enterome Series E round June 2020
$46.3m
Enterome Series B round May 2014
$10m
Industries
Enterome is active in the following industries: